BridgeMD
Tests treatment safety and results for Metabolic Syndrome (MetS)
Official title Efficacy of a Health Empowerment Theory Based Health Information Literacy Promotion Intervention in Individuals With Metabolic Syndrome
ClinicalTrials.gov ID: NCT07096102
What this study is testing
- What it's testing
- The ENRICH study is aimed to Enpower patieNts with metabolic syndrome (Mets) to increase their Risk perception and to acquire health Information necessary for Capability building and promotion of Health information literacy, as well as health outcomes. The purpose of this clinical trial is to evaluate the efficacy of this health information literacy promotion intervention based on Health Empowerment Theory in individuals with metabolic syndrome.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Age ≥ 18 years old and ≤ 75 years old;；
- Patients diagnosed with metabolic syndrome (meeting ≥3 criteria):
- Waist circumference ≥ 90 cm (men) / ≥ 85 cm (women)
- Fasting glucose ≥ 6.1 mmol/L or OGTT 2h-glucose ≥ 7.8 mmol/L and/or diabetes treatment
- Blood pressure ≥ 130/85 mmHg and/or hypertension treatment
You likely can't join if
- Patients with severe liver and kidney dysfunction, cancer, severe cardiovascular and cerebrovascular diseases, gout, etc., which seriously endanger...
- Pregnant patients；
- Patients with a history of mental illness and cognitive impairment；
- Those currently participating in other research projects.
See the full eligibility criteria
- Age ≥ 18 years old and ≤ 75 years old;；
- Patients diagnosed with metabolic syndrome (meeting ≥3 criteria):
- Waist circumference ≥ 90 cm (men) / ≥ 85 cm (women)
- Fasting glucose ≥ 6.1 mmol/L or OGTT 2h-glucose ≥ 7.8 mmol/L and/or diabetes treatment
- Blood pressure ≥ 130/85 mmHg and/or hypertension treatment
- Fasting triglycerides (TG) ≥ 1.70 mmol/L
- Fasting HDL-C \< 1.04 mmol/L；
- Aware of the condition, have basic reading and language communication skills, and voluntarily participate in this study
- Patients with severe liver and kidney dysfunction, cancer, severe cardiovascular and cerebrovascular diseases, gout, etc., which seriously endanger life, have abnormal nutritional status and require special diet;
- Pregnant patients；
- Patients with a history of mental illness and cognitive impairment；
- Those currently participating in other research projects.
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, Beijing Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, Beijing Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.